PEDIPPI Powder for oral suspension Ref.[27782] Active ingredients: Omeprazole

Source: Health Products Regulatory Authority (IE)  Revision Year: 2019  Publisher: Xeolas Pharmaceuticals Limited, Hamilton Building, DCU, Glasnevin, Dublin 9, Ireland

Product name and form

Pedippi 2 mg/ml powder for oral suspension.

Pharmaceutical Form

Powder for Oral Suspension.

Powder in Cap: White / off-white / slightly yellow powder.

Powder in Bottle: White / off-white / slightly yellow powder. May contain dark specks due to sweetener.

Qualitative and quantitative composition

After constitution, each ml of suspension contains 2 mg of omeprazole. Each constituted bottle (90 ml) contains 180 mg of omeprazole.

Excipients with known effect: Each ml of suspension contains sodium methyl parahydroxybenzoate (E219) 2.3 mg, maltitol (E965) 272 mg, sodium benzoate (E211) 5 mg, sodium 17.2 mg and potassium 54.3 mg.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Omeprazole

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.

List of Excipients

Sodium hydrogen carbonate (E500)
Potassium hydrogen carbonate (E501)
Sodium alginate (E401)
Maltitol (E965)
Mannitol (E421)
Sucralose (E955)
Xanthan gum (E415)
Natural Vanilla Flavouring containing Maltodextrin (Maize), silicon dioxide (E551) and vegetable oil fats
Natural Mint Flavouring containing Gum Arabic / Acacia Gum (E414) and pulegone
Titanium dioxide (E171)
Sodium benzoate (E211)
Sodium methyl parahydroxybenzoate (E219)

Pack sizes and marketing

Amber plastic (PET) bottle with powder fitted with a red Polypropylene (PP) closure cap containing powder, all enclosed in an aluminium foil pouch.

Each bottle contains 47 g of powder for oral suspension. Once constituted the bottle contains 90 ml of oral suspension, of which 75 ml is intended for dosing and administration.

Each pack also contains an opaque PP oral dosing syringe (5 ml, graduated at each 1ml and intermediate marks every 0.1ml) with white HDPE plunger, colourless, transparent LDPE bottle adaptor and grey PP replacement cap.

Pack: 1 or 2 bottles.

Not all pack sizes may be marketed

Marketing authorization holder

Xeolas Pharmaceuticals Limited, Hamilton Building, DCU, Glasnevin, Dublin 9, Ireland

Marketing authorization dates and numbers

PA1572/002/001

Date of first authorisation: 15th November 2019

Drugs

Drug Countries
PEDIPPI Ireland, Netherlands, New Zealand

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.